OMI - Owens & Minor, Inc.
| Previous Close | 3.4000 |
| Open | 3.3800 |
| Bid | 3.3900 x 2900 |
| Ask | 3.4000 x 1800 |
| Day's Range | 3.3350 - 3.5000 |
| 52 Week Range | 3.3350 - 19.1600 |
| Volume | 1,056,144 |
| Avg. Volume | 1,732,877 |
| Market Cap | 212.383M |
| Beta (3Y Monthly) | 2.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.2820 |
| Earnings Date | May 8, 2019 - May 13, 2019 |
| Forward Dividend & Yield | 0.01 (0.16%) |
| Ex-Dividend Date | 2019-03-14 |
| 1y Target Est | 5.63 |
- Markit•14 days ago
See what the IHS Markit Score report has to say about Owens & Minor Inc.
Owens & Minor Inc NYSE:OMIView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is high and has been increasing * Economic output in this company's sector is expanding Bearish sentimentShort interest | NegativeShort interest is high for OMI with between 15 and 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting OMI. Sentiment has worsened and traders added to their bearish short positions on April 1. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding OMI are favorable with net inflows of $73.59 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Business Wire•15 days ago
Owens & Minor Names Jeffrey Jochims as Executive Vice President, Strategy & Solutions
Today, Owens & Minor Inc. (OMI) announced the appointment of Jeffrey Jochims as Executive Vice President, Strategy & Solutions, effective April 8, 2019. Jochims, formerly a long-tenured executive at Thermo Fisher Scientific, joins the company with more than 25 years of business strategy and operations experience focused on distribution, manufacturing, and services in the healthcare, biopharmaceutical, and life sciences research industries. “We are delighted to bring someone with Jeff’s experience to our team,” said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor.
- GlobeNewswire•22 days ago
Report: Exploring Fundamental Drivers Behind Coeur Mining, Owens & Minor, Telenav, Cedar Realty Trust, j2 Global, and United Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, April 01, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Moody's•25 days ago
Owens & Minor Medical, Inc. -- Moody's downgrades Owens & Minor's CFR to B2; outlook is stable
Moody's Investors Service ("Moody's") downgraded Owens & Minor, Inc.'s Corporate Family Rating (CFR) to B2 from B1 and the Probability of Default Rating (PD) to B2-PD from B1-PD. Moody's also downgraded the ratings on the senior secured credit facilities and notes to B2 from B1. Concurrently, Moody's affirmed the SGL-3 Speculative Grade Liquidity Rating, signifying adequate liquidity.
- Insider Monkey•last month
Levin Capital and Other Hedge Funds Are Snapping Up Farmer Brothers Co. (FARM)
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent […]
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of OMI earnings conference call or presentation 20-Feb-19 1:30pm GMT
Q4 2018 Owens & Minor Inc Earnings Call
- Benzinga•2 months ago
Healthcare Logistics Company Owens & Minor Explores Sale After Earnings Misses
Owens & Minor (NYSE: OMI), a healthcare logistics company, is exploring a sale of itself after a series of disappointing earnings reports, according to sources quoted by Reuters in an exclusive report. The $420 million company, by market capitalization, lost 20 percent of its stock value this week after it failed to hit analysts' targets, Reuters reported. It is currently trading at just over five times earnings, according to market data.
- Moody's•2 months ago
Owens & Minor Medical, Inc. -- Moody's places Owens & Minor's ratings under review for downgrade
Moody's Investors Service ("Moody's") placed the ratings of Owens & Minor, Inc. ("OMI") on review for downgrade. This includes OMI's B1 Corporate Family Rating, its B1-PD Probability of Default Rating, and the B1 ratings on its senior secured bank facilities and senior secured notes. "The review for downgrade reflects the company's weak operating performance and free cash flow, as well as recent turnover in senior management" stated Jean-Yves Coupin, VP-Senior Analyst at Moody's. "These factors have contributed to financial leverage which is high for the B1 rating category", added Coupin.
- Reuters•2 months ago
Healthcare logistics company Owens & Minor explores sale: sources
The Richmond, Virginia-based company's shares tumbled as much as 20 percent on Wednesday, the day after it reported fourth-quarter earnings that missed analysts' expectations amid fierce price competition in its hospital supplies business. Owens & Minor, which has a market capitalization of $420 million, is working with investment banks to explore a sale, said the sources, who asked not to be named because the matter is confidential. Owens & Minor did not respond to a request for comment.
- MarketWatch•2 months ago
Owens & Minor's stock tumbles after dividend slashed to a penny, earnings miss
Shares of Owens & Minor Inc. tumbled 14% in active afternoon trade Wednesday, after the provider of distribution services to makers of healthcare products reported fourth-quarter earnings that missed expectations, provided a downbeat outlook and slashed its dividend to next to nothing. The company said late Tuesday it swung to a net loss of $261.8 million, or $4.37 a share, from a profit of $23.0 million, or 38 cents a share, in the same period a year ago. Excluding non-recurring items, such as $274 million impairment charge, adjusted earnings per share of 9 cents was below the FactSet consensus of 14 cents. Revenue rose 6.4% to $2.54 billion, above the FactSet consensus of $2.50 billion. The company said it amended its credit agreements, that while enhances it financial "flexibility," also increases its interest expense. With that in mind, the company expects 2019 adjusted EPS of 60 cents to 75 cents, below the current FactSet consensus of 93 cents. The company also cut its quarterly dividend to 0.25 cents a share from 7.5 cents a share, which lowers the implied annual dividend yield to 0.15% from 4.39%. Separately, Owens & Minor named Edward Pasicka its chief executive officer, effective March 4. The stock has plunged 56% over the past 12 months, while the S&P 500 has gained 2.5%.
Motley Fool•2 months agoOwens & Minor Inc (OMI) Q4 2018 Earnings Conference Call Transcript
OMI earnings call for the period ending December 31, 2018.
- Motley Fool•2 months ago
Why Owens & Minor Shares Are Tanking Today
Investors were disappointed by the company's lackluster Q4 earnings update.
- Associated Press•2 months ago
Owens & Minor: 4Q Earnings Snapshot
The Mechanicsville, Virginia-based company said it had a loss of $4.37 per share. Earnings, adjusted for asset impairment costs and costs related to mergers and acquisitions, came to 9 cents per share. ...
- Business Wire•2 months ago
Owens & Minor Reports 4th Quarter & Full-Year 2018 Financial Results
Owens & Minor, Inc. today reported financial results for the fourth quarter and the year ended December 31, 2018, as summarized in the table shown below.
- Business Wire•2 months ago
Owens & Minor Declares 1st Quarter 2019 Dividend
Owens & Minor, Inc. today announced that its Board of Directors has approved a first quarter dividend payment of $0.0025 per share. This dividend is payable on March 29, 2019, to shareholders of record as of March 15, 2019.
- Business Wire•2 months ago
Owens & Minor Names Ed Pesicka President and Chief Executive Officer
Owens & Minor Inc. (OMI) today announced that its Board of Directors has named Edward A. Pesicka President and Chief Executive Officer, effective March 4, 2019. Pesicka, a formerly long-tenured executive at Thermo Fisher Scientific, joins the Company with over 25 years of business and operational experience focused on distribution, manufacturing and service for the healthcare, pharmaceutical, biotechnology and scientific research industries. “The Board is extremely pleased to welcome Ed as the new CEO of Owens & Minor,” said Robert Sledd, Chairman and Interim President and Chief Executive Officer.
- Zacks•2 months ago
Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Business Wire•2 months ago
Owens & Minor will Report Fourth Quarter & Full Year 2018 Financial Results on Wednesday, February 20, 2019
Management’s conference call to discuss results planned for 8:30 a.m. EST on February 20
- Zacks•2 months ago
Earnings Preview: Owens & Minor (OMI) Q4 Earnings Expected to Decline
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire•3 months ago
Report: Exploring Fundamental Drivers Behind Realty Income, United Therapeutics, NxStage Medical, PTC Therapeutics, AVEO Pharmaceuticals, and Owens & Minor — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Jan. 28, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Simply Wall St.•3 months ago
Owens & Minor, Inc. (NYSE:OMI) Investors Are Paying Above The Intrinsic Value
Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of Owens & Minor, Inc. (NYSE:OMI) as an investment opportunity by taking Read More...
